Bone morphogenetic proteins (BMPs) play pivotal roles in the regulation of skin development. To study the role of BMPs in skin tumorigenesis, BMP antagonist noggin was used to generate keratin 14-targeted transgenic mice. In contrast to wild-type mice, transgenic mice developed spontaneous hair follicle-derived tumors, which resemble human trichofolliculoma. Global gene expression profiles revealed that in contrast to anagen hair follicles of wild-type mice, Skin cancer is the most common cancer in the United States, Europe, and other countries, and the incidence continues to increase. 1 During the last decade, considerable progress has been achieved in identification of molecular mechanisms underlying the development of the major cutaneous cancers, such as malignant melanoma, basal cell carcinoma, and squamous cell carcinoma. 2,3 In particular, it was shown that mechanisms controlling skin development and carcinogenesis appear to be very similar, and key signaling pathways (Wnt, hedgehog, notch, transforming growth factor-, etc) that regulate skin development are also implicated in the pathobiology of cutaneous neoplasias [reviewed in [1][2][3][4][5] ].Bone morphogenetic protein (BMP) signaling plays pivotal roles in the control of cutaneous development and also possesses a potent antitumor activity in postnatal skin [for review see 6,7 ]. BMP signaling is activated by binding of the BMP ligands to BMP receptors (BMPRs) followed by activation of the BMP-Smad and/or BMP-MAP kinase pathways.